Skip to main content

Advertisement

Table 1 Demographic characteristics of the study groups at baseline

From: Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia

  Diet (n = 14) Diet-plus-statin (n = 14) P value
Age (years) 63.9 ± 3.3 60.6 ± 3.4 0.492
Gender (female/male) 4/10 4/10 0.661
Body mass Index (kg/m2) 24.4 ± 0.7 24.3 ± 0.9 0.934
Current smoking (n (%)) 1 (7) 2 (14) 0.500
Alcohol (n (%)) 4 (29) 3 (21) 0.500
Diabetes mellitus (n (%)) 4 (29) 5 (36) 0.500
Hypertention (n (%)) 12 (86) 12 (86) 0.702
Cerebrovascular disease (n (%)) 0 (0) 1 (7) 0.500
Ischemic heart disease (n (%)) 0 (0) 1 (7) 0.500
Cause of CKD (n (%)):    0.318
 Diabetic nephropathy 1 (7) 2 (14)  
 Chronic glomerulonephritis 6 (43) 7 (50)  
 Nephrosclerosis 6 (43) 4 (29)  
 Others 1 (7) 1 (7)  
Systolic BP (mmHg) 133 ± 4 127 ± 4 0.306
Diastolic BP (mmHg) 79 ± 2 76 ± 2 0.435
Heart rate (beats/min) 69 ± 3 74 ± 2 0.239
Plasma glucose (mg/dL) 113 ± 7 107 ± 4 0.614
HbA1c (%) 5.6 ± 0.1 5.6 ± 0.1 0.946
TC (mg/dL) 211 ± 6 207 ± 7 0.620
LDL-C (mg/dL) 139 ± 6 136 ± 6 0.797
HDL-C (mg/dL) 56 ± 3 56 ± 4 0.966
TG (mg/dL) 145 ± 14 154 ± 20 0.715
AST (U/L) 24 ± 1 20 ± 1 0.035
ALT (U/L) 22 ± 2 20 ± 3 0.265
Creatine kinase (U/L) 110 ± 13 106 ± 13 0.946
Serum creatinine (mg/dL) 1.2 ± 0.1 1.3 ± 0.1 0.593
Estimated GFR (mL/min/1.73 m2) 50.1 ± 4.9 48.6 ± 4.7 0.827
GFR category (n (%)):    0.500
 G1 1 (7) 0 (0)  
 G2 2 (14) 4 (29)  
 G3a 5 (36) 3 (21)  
 G3b 5 (36) 6 (43)  
 G4 1 (7) 1 (7)  
 G5 0 (0) 0 (0)  
UACR (mg/g-Cr) 1025 ± 465 801 ± 254 0.946
Albuminuria category (n (%)):    1.000
 A2 7 (50) 7 (50)  
 A3 7 (50) 7 (50)  
  1. Values are means ± SE or number (percentage). CKD chronic kidney disease, BP blood pressure, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride, AST aspartate transaminase, ALT alanine transaminase, GFR glomerular filtration rate, UACR urine albumin-to-creatinine ratio